Experimental Hematology
Volume 38, Issue 1 , Pages 38-45, January 2010

Coexpression of CD44 variant isoforms and receptor for hyaluronic acid−mediated motility (RHAMM, CD168) is an International Prognostic Index and C-MYC gene status−independent predictor of poor outcome in diffuse large B-cell lymphomas

  • Sabine Nagel

      Affiliations

    • Institute of Pathology, Basel, Switzerland
    • Technical University of Berlin, Berlin, Germany
    • ,
  • Petra Hirschmann

      Affiliations

    • Institute of Pathology, Basel, Switzerland
    • ,
  • Stephan Dirnhofer

      Affiliations

    • Institute of Pathology, Basel, Switzerland
    • ,
  • Ursula Günthert

      Affiliations

    • Institute of Pathology, Basel, Switzerland
    • ,
  • Alexandar Tzankov

      Affiliations

    • Institute of Pathology, Basel, Switzerland
    • Corresponding Author InformationOffprint requests to: Alexandar Tzankov, M.D., Institute of Pathology, Schönbeinstrasse 40, CH 4031 Basel, Switzerland

Received 24 August 2009; received in revised form 19 October 2009; accepted 20 October 2009. published online 26 October 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0301-472X(09)00401-9

doi:10.1016/j.exphem.2009.10.010

Experimental Hematology
Volume 38, Issue 1 , Pages 38-45, January 2010

Article Tools

* Image Usage & Resolution